Bioventus Secures BCBS Coverage for OA Treatments
Bioventus secured preferred access to DUROLANE, GELSYN-3 and SUPARTZ FX to treat knee OA pain for certain Blue Cross Blue Shield of Michigan patients. ...
Bioventus secured preferred access to DUROLANE, GELSYN-3 and SUPARTZ FX to treat knee OA pain for certain Blue Cross Blue Shield of Michigan patients. ...
In2Bones commenced global launch of the AlloAid BioNailâ„¢ engineered allograft implant for reconstructive surgery of the hand and foot....
Hensler Surgical filed a lawsuit against Tobra Medical, alleging patent infringement relative to the Tobra Medical Bone Basket....
Anika Therapeutics is commencing full U.S. commercial launch of TACTOSET surgically-delivered therapy for bone repair procedures....
FDA approved Cerapedics' Premarket Approval supplement for i-FACTOR® Peptide Enhanced Bone Graft for use in ACDF to treat degenerative cervical disc disease....
Personalized Stem Cells treated the first patients in an FDA-approved clinical trial for stem cell treatment of knee osteoarthritis....
In2Bones commenced U.S. launch of the CoLink® Bone Graft Harvester and Tribio™ Backfill Plug System....
GID BIO completed a Phase IIb clinical trial using autologous stromal cells in the treatment of knee osteoarthritis....
BBS-Bioactive Bone Substitutes' patent application regarding a bone protein preparation has been accepted in Canada....
Creative Medical Technology will begin U.S. commercialization of StemSpine®, a regenerative stem cell procedure for the treatment of degenerative disc disease....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.